Spondyloarthritis Biologics 'Game-Changing' for Juvenile Disease
(MedPage Today) -- Researchers continue to lay the groundwork for expanding treatment in juvenile spondyloarthritis (SpA), borrowing from advances in disease-modifying anti-rheumatic drugs (DMARDs) in adults. Earlier this year, the interleukin...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.